Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertensionheart failure and percutenous coronary interventions (PCI).

Videos | Congenital Heart | September 15, 2021
Tom Jones, M.D., director, cardiac cath labs, Seattle Children’s Hospital, explains the importance of the heart team...
Feature | Cath Lab | September 14, 2021 | By Aaron Detate and Lars Thording
In the electrophysiology (EP) lab, hundreds of thousands of used devices are sent to reprocessors every year to get...
Non-invasive evaluation of heart valves using echocardiography first, and other cardiac imaging techniques when needed, is the key evaluation of heart valves in the new ESC and European Association for Cardio-Thoracic Surgery (EACTS) Guidelines for the management of valvular heart disease. Photo by Dave Fornell.

Non-invasive evaluation of heart valves using echocardiography first, and other cardiac imaging techniques when needed, is the key evaluation of heart valves in the new ESC and European Association for Cardio-Thoracic Surgery (EACTS) Guidelines for the management of valvular heart disease. Photo by Dave Fornell.

News | Structural Heart | September 13, 2021
September 13, 2021 — The European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (...
Siemens Artis Q angiography system #ESC #ESCcongress
News | Sudden Cardiac Arrest | September 13, 2021
September 13, 2021 — Early coronary angiography in out-of-hospital cardiac arrest (OHCA) patients without ST-segment...
Systematic FFR Assessment Did Not Add Benefit During Diagnostic Angiography.
News | FFR Technologies | September 08, 2021
September 8, 2021 — Adding systematic fractional flow reserve (FFR) assessment to coronary angiography does not reduce...
A 3-D CT reconstructed image showing a narrow lesion at the carotid bifurcation. ACST-2 was the largest trial to compare the long-term effect of carotid artery stenting (CAS) and carotid endarterectomy (CEA) on stroke in asymptomatic patients with a severely narrowed carotid artery that had not yet caused a stroke. Image by Canon

A 3-D CT reconstructed image showing a narrow lesion at the carotid bifurcation. ACST-2 was the largest trial to compare the long-term effect of carotid artery stenting (CAS) and carotid endarterectomy (CEA) on stroke in asymptomatic patients with a severely narrowed carotid artery that had not yet caused a stroke. Image by Canon

News | Stroke | September 07, 2021
September 7, 2021 — Carotid artery surgery and stenting have comparable long-term effects on fatal or disabling stroke...
One-month Clopidogrel Monotherapy After PCI Not Supported in STOPDAPT-2 ACS Trial 
News | Antiplatelet and Anticoagulation Therapies | September 01, 2021
September 1, 2021 — The STOPDAPT-2 ACS trial does not support the use of one month of dual antiplatelet therapy (DAPT)...
The anticoagulant edoxaban (Savaysa) may be just as effective as warfarin for preventing heart attack or stroke in patients with AFib who undergo transcatheter aortic valve replacement (TAVR), according to an ESC late-breaking trial.

The anticoagulant edoxaban (Savaysa) may be just as effective as warfarin for preventing heart attack or stroke in patients with AFib who undergo transcatheter aortic valve replacement (TAVR), according to an ESC late-breaking trial.

News | Antiplatelet and Anticoagulation Therapies | September 01, 2021
September 1, 2021 – The anticoagulant edoxaban (Savaysa) may be just as effective as warfarin for preventing heart...
Abbott Amplatzer Amulet LAA Occluder Offers Superior Closure Compared to Watchman
News | Left Atrial Appendage (LAA) Occluders | August 31, 2021
August 31, 2021 — Late-breaking data from a head-to-head clinical trial of the Amulet Left Atrial Appendage (LAA)...
The Abbott Amplatzer Amulet left atrial appendage (LAA) transcatheter occlusion device. It received FDA clearance in August 2021. #LAA

The Abbott Amplatzer Amulet left atrial appendage (LAA) transcatheter occlusion device. It received FDA clearance in August 2021.

News | Left Atrial Appendage (LAA) Occluders | August 16, 2021
August 16, 2021 — The U.S. Food and Drug Administration (FDA) approved Abbott's Amplatzer Amulet Left Atrial Appendage...
Boston Scientific Corp. has commenced enrollment in the HI-PEITHO clinical trial, a collaborative research study with the Pulmonary Embolism Response Team (PERT) Consortium and the University Medical Center of the Johannes Gutenberg University of Mainz comparing use of the EkoSonic Endovascular System in combination with anticoagulation to anticoagulation alone for the treatment of acute, intermediate-high-risk pulmonary embolism (PE).
News | Pulmonary Embolism | August 09, 2021
August 9, 2021 — Boston Scientific Corp. has commenced enrollment in the HI-PEITHO clinical trial, a collaborative...
Abbott's new interventional imaging platform powered by Ultreon 1.0 Software is a first-of-its-kind imaging software merges optical coherence tomography (OCT) intravascular imaging with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting procedures.

Abbott's new interventional imaging platform powered by Ultreon 1.0 Software is a first-of-its-kind imaging software merges optical coherence tomography (OCT) intravascular imaging with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting procedures.

News | Optical Coherence Tomography (OCT) | August 05, 2021
August 5, 2021 — The U.S. Food and Drug Administration (FDA) has cleared clearance Abbott's latest optical coherence...
Innovative Health Inc. announced several new initiatives to increase savings from single-use device reprocessing in the electrophysiology (EP) lab. #HRS21 #HRS2021 #Heartrhythm21
News | EP Lab | July 30, 2021
July 30, 2021 – Innovative Health Inc. announced several new initiatives to increase savings from single-use device...

An IVC filter seen under X-ray, left. Right, two sizes of the Philips excimer laser technology currently on the U.S. market for EP lead extraction. The CO2 laser technology is able to gently ablate scar tissue encasing leads to enable their extraction. 

News | Inferior Vena Cava Filters | July 27, 2021
July 27, 2021 — The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to a...
The CathWorks angiography image derived FFR assessment system has received national reimbursement approval in Japan. The system uses a rotational angiography image dataset taken while the patient is in the cath lab to quickly reconstruct a 3-D coronary tree showing FFR numbers for all of the artery segments. 

The CathWorks angiography image derived FFR assessment system has received national reimbursement approval in Japan. The system uses a rotational angiography image dataset taken while the patient is in the cath lab to quickly reconstruct a 3-D coronary tree showing FFR numbers for all of the artery segments. 

News | FFR Technologies | July 26, 2021
July 26, 2021 – CathWorks announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the...